Home/Filings/4/0001213900-23-096502
4//SEC Filing

Woody James N. 4

Accession 0001213900-23-096502

CIK 0001690080other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:15 PM ET

Size

5.1 KB

Accession

0001213900-23-096502

Insider Transaction Report

Form 4
Period: 2023-12-15
Woody James N.
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2023-12-15$0.19/sh+25,000$4,70066,888 total
Footnotes (1)
  • [F1]Effective on December 15, 2023, Dr. James N. Woody, the Chief Executive Officer of the Issuer, purchased 25,000 shares of common stock of the Issuer from Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date.

Documents

1 file

Issuer

180 Life Sciences Corp.

CIK 0001690080

Entity typeother

Related Parties

1
  • filerCIK 0001553355

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:15 PM ET
Size
5.1 KB